RxDoctor Payments Data

Wendy Dinkel, DO

Family Medicine · Lindsborg, KSNPI 1730400219

Payments from drug & device makers

$213in general payments, 2019–2025

Across 14 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$55
  • AstraZeneca$45
  • Novo Nordisk$21
  • GSK$18
  • Lilly USA, LLC$16
  • Exact Sciences$16
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$17180%
  • Education$4220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$213 in reported general payments places this provider in the 35th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$54,099
Medicare patients
86
Services billed
868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$83,006
FarxigaDapagliflozin Propanediol82$48,330
TrulicityDulaglutide47$41,620
MounjaroTirzepatide35$35,616
XareltoRivaroxaban30$25,601
MyrbetriqMirabegron46$17,157
JardianceEmpagliflozin11$15,247
OzempicSemaglutide15$14,341
Breo ElliptaFluticasone/Vilanterol16$9,602
Repatha SureclickEvolocumab13$7,331
Xigduo XrDapaglifloz Propaned/Metformin12$6,400
BelsomraSuvorexant12$4,899
Pantoprazole Sodium133$4,895
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$4,554
VascepaIcosapent Ethyl11$3,718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$16$77,23782 claims
AstraZenecaFarxiga$45$48,33082 claims
Novo NordiskOzempic$21$14,34115 claims
GSKBreo Ellipta$18$9,60216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Lindsborg

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →